Skip to main content
Top
Published in: Supportive Care in Cancer 3/2007

Open Access 01-03-2007 | Original Article

Testicular cancer: a longitudinal pilot study on stress response symptoms and quality of life in couples before and after chemotherapy

Authors: Marrit A. Tuinman, Harald J. Hoekstra, Dirk Th. Sleijfer, Joke Fleer, Damon J. Vidrine, Ellen R. Gritz, Josette E. H. M. Hoekstra-Weebers

Published in: Supportive Care in Cancer | Issue 3/2007

Login to get access

Abstract

Goals of work

The current study was designed to longitudinally examine stress response symptoms (SRS) and quality of life (QoL) in couples confronted with disseminated testicular cancer. The objectives were to examine couples’ patterns of adjustment over time and possible differences in adjustment between the patient and his partner.

Materials and methods

Couples completed the Impact of Event Scale and the QoL subscales physical functioning, social functioning, and mental health of the RAND-36 before chemotherapy (T1), after completion of chemotherapy (T2), and 1 year later (T3).

Results

Before chemotherapy 26% of the patients and 50% of partners reported clinically elevated levels of SRS. Patients reported lower physical and social functioning at T2 compared to T1 and T3. Partners reported an improvement in social functioning over the year and no changes in physical functioning or mental health. No relationships between patients and partners’ functioning were found. One year after diagnosis, QoL of patients and partners was similar to that of reference groups, and patients even reported better physical functioning than the reference group. SRS of patients and partners were negatively related at T1, and patients and partners’ social functioning were positively related at T2.

Conclusions

According to stress response levels, the period before the start of chemotherapy was most stressful for couples. Adjustment patterns differ between testicular cancer patients and their partners with patients reporting lowered QoL after completion of chemotherapy. QoL of couples returned to normal levels 1 year after diagnosis. The effect of disseminated testicular cancer on the QoL of patients and their partners seems to be temporary. A minority may need clinical attention for severe SRS.
Literature
1.
go back to reference Visser O, Siesling S, Van Dijck JAAM (2005) Incidence of cancer in The Netherlands 1999/2000. Eleventh report of The Netherlands Cancer Registry. Association of Comprehensive Cancer Centres, 2003. Association of Comprehensive Cancer Centres, pp 27–24 Visser O, Siesling S, Van Dijck JAAM (2005) Incidence of cancer in The Netherlands 1999/2000. Eleventh report of The Netherlands Cancer Registry. Association of Comprehensive Cancer Centres, 2003. Association of Comprehensive Cancer Centres, pp 27–24
2.
go back to reference Shelley MD, Burgon K, Mason MD (2002) Treatment of testicular germ-cell cancer: a cochrane evidence-based systematic review. Cancer Treat Rev 28:237–253PubMedCrossRef Shelley MD, Burgon K, Mason MD (2002) Treatment of testicular germ-cell cancer: a cochrane evidence-based systematic review. Cancer Treat Rev 28:237–253PubMedCrossRef
3.
go back to reference Jones RH, Vasey PA (2003) Part II: testicular cancer—management of advanced disease. Lancet Oncol 4:738–747PubMedCrossRef Jones RH, Vasey PA (2003) Part II: testicular cancer—management of advanced disease. Lancet Oncol 4:738–747PubMedCrossRef
4.
go back to reference Vaughn DJ, Gignac GA, Meadows AT (2002) Long-term medical care of testicular cancer survivors. Ann Intern Med 136(6):463–470PubMed Vaughn DJ, Gignac GA, Meadows AT (2002) Long-term medical care of testicular cancer survivors. Ann Intern Med 136(6):463–470PubMed
5.
go back to reference Sonneveld DJA, Hoekstra HJ, van der Graaf WT, Sluiter WJ, Mulder NH, Willemse PHB, Koops HS, Sleijfer DT (2001) Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era. Cancer 91(7):1304–1315PubMedCrossRef Sonneveld DJA, Hoekstra HJ, van der Graaf WT, Sluiter WJ, Mulder NH, Willemse PHB, Koops HS, Sleijfer DT (2001) Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era. Cancer 91(7):1304–1315PubMedCrossRef
6.
go back to reference Dahl AA, Mykletun A, Fossa SD (2005) Quality of life in survivors of testicular cancer. Urol Oncol 23(13):193–200PubMed Dahl AA, Mykletun A, Fossa SD (2005) Quality of life in survivors of testicular cancer. Urol Oncol 23(13):193–200PubMed
7.
go back to reference Fossa SD, Dahl AA, Loge JH (2003) Fatigue, anxiety, and depression in long-term survivors of testicular cancer. J Clin Oncol 21(7):1249–1254PubMedCrossRef Fossa SD, Dahl AA, Loge JH (2003) Fatigue, anxiety, and depression in long-term survivors of testicular cancer. J Clin Oncol 21(7):1249–1254PubMedCrossRef
8.
go back to reference Iconomou G, Mega V, Koutras A, Iconomou AV, Kalofonos HP (2004) prospective assessment of emotional distress, cognitive function, and quality of life in patients with cancer treated with chemotherapy. Cancer 101(2):404–411PubMedCrossRef Iconomou G, Mega V, Koutras A, Iconomou AV, Kalofonos HP (2004) prospective assessment of emotional distress, cognitive function, and quality of life in patients with cancer treated with chemotherapy. Cancer 101(2):404–411PubMedCrossRef
9.
go back to reference Knobf MT, Pasacreta JV, Valentine A, McCorkle R (1998) Chemotherapy, hormonal therapy, and immunotherapy. In: Holland JC (ed) Psycho-oncology. Oxford University Press, New York, pp 277–288 Knobf MT, Pasacreta JV, Valentine A, McCorkle R (1998) Chemotherapy, hormonal therapy, and immunotherapy. In: Holland JC (ed) Psycho-oncology. Oxford University Press, New York, pp 277–288
10.
go back to reference Vidrine DJ, Gritz ER (2003) Psychosocial outcomes after testicular cancer treatment. In: Steele GD Jr, Phillips TL, Chabner BA, Gansler TS (eds) Germ cell tumors, American Cancer Society Atlas of Clinical Oncology. BC Decker, Hamilton, London, pp 295–305 Vidrine DJ, Gritz ER (2003) Psychosocial outcomes after testicular cancer treatment. In: Steele GD Jr, Phillips TL, Chabner BA, Gansler TS (eds) Germ cell tumors, American Cancer Society Atlas of Clinical Oncology. BC Decker, Hamilton, London, pp 295–305
11.
go back to reference Kim Y, Duberstein PR, Sörensen S, Larson MR (2005) Levels of depressive symptoms in spouses of people with lung cancer: effects of personality, social support and caregiver burden. Psychosomatics 46(2):123–130PubMedCrossRef Kim Y, Duberstein PR, Sörensen S, Larson MR (2005) Levels of depressive symptoms in spouses of people with lung cancer: effects of personality, social support and caregiver burden. Psychosomatics 46(2):123–130PubMedCrossRef
12.
go back to reference Hagedoorn M, Sanderman R, Buunk BP, Wobbes T (2002) Failing in spousal caregiving: the ‘identity-relevant stress’ hypothesis to explain sex differences in caregiver distress. Br J Health Psychol 7:481–494PubMedCrossRef Hagedoorn M, Sanderman R, Buunk BP, Wobbes T (2002) Failing in spousal caregiving: the ‘identity-relevant stress’ hypothesis to explain sex differences in caregiver distress. Br J Health Psychol 7:481–494PubMedCrossRef
13.
go back to reference Nijboer C, Triemstra M, Tempelaar R, Sanderman R, Van den Bos GAM (1999) Determinants of caregiving experiences and mental health of partners of cancer patients. Cancer 86(4):577–588PubMedCrossRef Nijboer C, Triemstra M, Tempelaar R, Sanderman R, Van den Bos GAM (1999) Determinants of caregiving experiences and mental health of partners of cancer patients. Cancer 86(4):577–588PubMedCrossRef
14.
go back to reference Schover LR, von Eschenbach AC (1985) Sexual and marital relationships after treatment for nonseminomatous testicular cancer. Urology 25(3):251–255PubMedCrossRef Schover LR, von Eschenbach AC (1985) Sexual and marital relationships after treatment for nonseminomatous testicular cancer. Urology 25(3):251–255PubMedCrossRef
15.
go back to reference Schover LR, Gonzales M, von Eschenbach AC (1986) Sexual and marital relationships after radiotherapy for seminoma. Urology 27(2):117–123PubMedCrossRef Schover LR, Gonzales M, von Eschenbach AC (1986) Sexual and marital relationships after radiotherapy for seminoma. Urology 27(2):117–123PubMedCrossRef
16.
go back to reference Gritz ER, Wellisch DK, Wang HJ, Siau J, Landsverk JA, Cosgrove MD (1989) Long-term effects of testicular cancer on sexual functioning in married couples. Cancer 64(7):1560–1567PubMedCrossRef Gritz ER, Wellisch DK, Wang HJ, Siau J, Landsverk JA, Cosgrove MD (1989) Long-term effects of testicular cancer on sexual functioning in married couples. Cancer 64(7):1560–1567PubMedCrossRef
17.
go back to reference Baider L, Koch U, Esacson R, De Nour AK (1998) Prospective study of cancer patients and their spouses: the weakness of marital strength. Psychooncology 7(1):49–56PubMedCrossRef Baider L, Koch U, Esacson R, De Nour AK (1998) Prospective study of cancer patients and their spouses: the weakness of marital strength. Psychooncology 7(1):49–56PubMedCrossRef
18.
go back to reference Keller M, Henrich G, Sellschopp A, Beutel M (1996) Between distress and support: spouses of cancer patients. In: Baider L, Cooper CL, Kaplan De-Nour A (eds) Cancer and the family. Wiley, Chichester, England, pp 187–223 Keller M, Henrich G, Sellschopp A, Beutel M (1996) Between distress and support: spouses of cancer patients. In: Baider L, Cooper CL, Kaplan De-Nour A (eds) Cancer and the family. Wiley, Chichester, England, pp 187–223
19.
go back to reference Northouse LL, Mood D, Templin T, Mellon S, George T (2000) Couples’ patterns of adjustment to colon cancer. Soc Sci Med 50:271–284PubMedCrossRef Northouse LL, Mood D, Templin T, Mellon S, George T (2000) Couples’ patterns of adjustment to colon cancer. Soc Sci Med 50:271–284PubMedCrossRef
20.
go back to reference Tuinstra J, Hagedoorn M, Van Sonderen E, Ranchor AV, Van den Bos GAM, Nijboer C, Sanderman R (2004) Psychological distress in couples dealing with colorectal cancer: gender and role differences and intracouple correspondence. Br J Health Psychol 9:465–478PubMedCrossRef Tuinstra J, Hagedoorn M, Van Sonderen E, Ranchor AV, Van den Bos GAM, Nijboer C, Sanderman R (2004) Psychological distress in couples dealing with colorectal cancer: gender and role differences and intracouple correspondence. Br J Health Psychol 9:465–478PubMedCrossRef
21.
go back to reference Hagedoorn M, Tuinstra J (2003) Living together with cancer. The emotional well-being of patients and their partners. Gedrag Gezond (Behavior and Health) 30(3):193–203 Hagedoorn M, Tuinstra J (2003) Living together with cancer. The emotional well-being of patients and their partners. Gedrag Gezond (Behavior and Health) 30(3):193–203
22.
go back to reference Matthews AB (2003) Role and gender differences in cancer-related distress: a comparison of survivor and caregiver self-reports. Oncol Nurs Forum 30(3):493–499PubMed Matthews AB (2003) Role and gender differences in cancer-related distress: a comparison of survivor and caregiver self-reports. Oncol Nurs Forum 30(3):493–499PubMed
23.
go back to reference Trask PC, Paterson AG, Fardig J, Smith DC (2003) Course of distress and quality of life in testicular cancer patients before, during, and after chemotherapy: results of a pilot study. Psychooncology 12:814–820PubMedCrossRef Trask PC, Paterson AG, Fardig J, Smith DC (2003) Course of distress and quality of life in testicular cancer patients before, during, and after chemotherapy: results of a pilot study. Psychooncology 12:814–820PubMedCrossRef
24.
go back to reference Fossa SD, de Wit R, Trevor Roberts J, Wilkinson PM, de Mulder PHM, Mead GM, Cook P, de Prijck L, Stenning S, Aaronson NK, Bottomley A, Collette L (2003) Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20). J Clin Oncol 21(6):1107–1118PubMedCrossRef Fossa SD, de Wit R, Trevor Roberts J, Wilkinson PM, de Mulder PHM, Mead GM, Cook P, de Prijck L, Stenning S, Aaronson NK, Bottomley A, Collette L (2003) Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20). J Clin Oncol 21(6):1107–1118PubMedCrossRef
25.
go back to reference Holzik MFL, Rapley EA, Hoekstra HJ, Sleijfer DT, Nolte IM, Sijmons RH (2004) Genetic predisposition to testicular germ-cell tumours. Lancet Oncol 5(6):363–371CrossRef Holzik MFL, Rapley EA, Hoekstra HJ, Sleijfer DT, Nolte IM, Sijmons RH (2004) Genetic predisposition to testicular germ-cell tumours. Lancet Oncol 5(6):363–371CrossRef
26.
go back to reference Jonker-Pool G, van de Wiel HB, Hoekstra HJ, Sleijfer DT, van Driel MF, van Basten JP, Schraffordt Koops HS (2001) Sexual functioning after treatment for testicular cancer-review and meta-analysis of 36 empirical studies between 1975–2000. Arch Sex Behav 30(1):55–74PubMedCrossRef Jonker-Pool G, van de Wiel HB, Hoekstra HJ, Sleijfer DT, van Driel MF, van Basten JP, Schraffordt Koops HS (2001) Sexual functioning after treatment for testicular cancer-review and meta-analysis of 36 empirical studies between 1975–2000. Arch Sex Behav 30(1):55–74PubMedCrossRef
27.
go back to reference Nuver J, Smit AJ, Postma A, Sleijfer DT, Gietema JA (2002) The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures. Cancer Treat Rev 28(4):195–214PubMedCrossRef Nuver J, Smit AJ, Postma A, Sleijfer DT, Gietema JA (2002) The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures. Cancer Treat Rev 28(4):195–214PubMedCrossRef
29.
go back to reference Fleer J, Hoekstra HJ, Sleijfer DT, Tuinman MA, Klip EC, Hoekstra-Weebers JEHM (2006) Quality of life of testicular cancer survivors and the relationship with sociodemographics, cancer-related variables and life events. Support Care Cancer 12(7):476–486 Fleer J, Hoekstra HJ, Sleijfer DT, Tuinman MA, Klip EC, Hoekstra-Weebers JEHM (2006) Quality of life of testicular cancer survivors and the relationship with sociodemographics, cancer-related variables and life events. Support Care Cancer 12(7):476–486
30.
go back to reference Tuinman MA, Fleer J, Hoekstra HJ, Sleijfer DT, Hoekstra-Weebers JEHM (2004) Quality of life and stress response symptoms in long-term and recent spouses of testicular cancer survivors. Eur J Cancer 40(11):1696–1703PubMedCrossRef Tuinman MA, Fleer J, Hoekstra HJ, Sleijfer DT, Hoekstra-Weebers JEHM (2004) Quality of life and stress response symptoms in long-term and recent spouses of testicular cancer survivors. Eur J Cancer 40(11):1696–1703PubMedCrossRef
31.
go back to reference Gritz ER, Wellisch DK, Landsverk JA (1988) Psychosocial sequelae in long-term survivors of testicular cancer. J Psychosoc Oncol 6(3/4):41–63CrossRef Gritz ER, Wellisch DK, Landsverk JA (1988) Psychosocial sequelae in long-term survivors of testicular cancer. J Psychosoc Oncol 6(3/4):41–63CrossRef
32.
go back to reference Gritz ER, Wellisch DK, Siau J, Wang HJ (1990) Long-term effects of testicular cancer on marital relationships. Psychosomatics 31(3):301–312PubMed Gritz ER, Wellisch DK, Siau J, Wang HJ (1990) Long-term effects of testicular cancer on marital relationships. Psychosomatics 31(3):301–312PubMed
33.
go back to reference Tuinman MA, Fleer J, Sleijfer DT, Hoekstra HJ, Hoekstra-Weebers JEHM (2005) Marital and sexual satisfaction in testicular cancer survivors and their spouses. Support Care Cancer 13(7):540–548PubMedCrossRef Tuinman MA, Fleer J, Sleijfer DT, Hoekstra HJ, Hoekstra-Weebers JEHM (2005) Marital and sexual satisfaction in testicular cancer survivors and their spouses. Support Care Cancer 13(7):540–548PubMedCrossRef
34.
go back to reference Gurevich M, Devins GM, Rodin GM (2002) Stress response syndromes and cancer: conceptual and assessment issues. Psychosomatics 43(4):259–281PubMedCrossRef Gurevich M, Devins GM, Rodin GM (2002) Stress response syndromes and cancer: conceptual and assessment issues. Psychosomatics 43(4):259–281PubMedCrossRef
35.
go back to reference Horowitz M, Wilner N, Alvarez W (1979) Impact of event scale: a measure of subjective stress. Psychosom Med 41(3):209–218PubMed Horowitz M, Wilner N, Alvarez W (1979) Impact of event scale: a measure of subjective stress. Psychosom Med 41(3):209–218PubMed
36.
go back to reference van der Ploeg E, Mooren TTM, Kleber RJ, van der Velden PG, Brom D (2004) Construct validation of the Dutch version of the impact of event scale. Psychol Assess 16(1):16–26PubMedCrossRef van der Ploeg E, Mooren TTM, Kleber RJ, van der Velden PG, Brom D (2004) Construct validation of the Dutch version of the impact of event scale. Psychol Assess 16(1):16–26PubMedCrossRef
37.
go back to reference Sundin EC, Horowitz MJ (2002) Impact of event scale: psychometric properties. Br J Psychiatry 180(3):205–209PubMedCrossRef Sundin EC, Horowitz MJ (2002) Impact of event scale: psychometric properties. Br J Psychiatry 180(3):205–209PubMedCrossRef
38.
go back to reference Thewes B, Meiser B, Hickie IB (2001) Psychometric properties of the impact of event scale amongst women at increased risk for hereditary breast cancer. Psychooncology 10:459–468PubMedCrossRef Thewes B, Meiser B, Hickie IB (2001) Psychometric properties of the impact of event scale amongst women at increased risk for hereditary breast cancer. Psychooncology 10:459–468PubMedCrossRef
40.
go back to reference Manne S (1998) Cancer in the marital context: a review of the literature. Cancer Invest 16(3):188–202PubMed Manne S (1998) Cancer in the marital context: a review of the literature. Cancer Invest 16(3):188–202PubMed
41.
go back to reference Eton DT, Lepore SJ, Helgeson VS (2005) Psychological distress in spouses of men treated for early-stage prostate carcinoma. Cancer 103(11):2412–2418PubMedCrossRef Eton DT, Lepore SJ, Helgeson VS (2005) Psychological distress in spouses of men treated for early-stage prostate carcinoma. Cancer 103(11):2412–2418PubMedCrossRef
42.
go back to reference Rees J, Clarke MG, Waldron D, O’Boyle C, Ewings P, MacDonagh RP (2005) The measurement of response shift in patients with advanced prostate cancer and their partners. Health Qual Life Outcomes 3:21PubMedCrossRef Rees J, Clarke MG, Waldron D, O’Boyle C, Ewings P, MacDonagh RP (2005) The measurement of response shift in patients with advanced prostate cancer and their partners. Health Qual Life Outcomes 3:21PubMedCrossRef
43.
go back to reference Stoter G, Koopman A, Vendrik CPJ, Struyvenberg A, Sleyfer DT, Willemse PHB, Koops HS, Vanoosterom AT, Huinink WWT, Pinedo HM (1989) 10-year survival and late sequelae in testicular cancer-patients treated with cisplatin, vinblastine, and bleomycin. J Clin Oncol 7(8):1099–1104PubMed Stoter G, Koopman A, Vendrik CPJ, Struyvenberg A, Sleyfer DT, Willemse PHB, Koops HS, Vanoosterom AT, Huinink WWT, Pinedo HM (1989) 10-year survival and late sequelae in testicular cancer-patients treated with cisplatin, vinblastine, and bleomycin. J Clin Oncol 7(8):1099–1104PubMed
Metadata
Title
Testicular cancer: a longitudinal pilot study on stress response symptoms and quality of life in couples before and after chemotherapy
Authors
Marrit A. Tuinman
Harald J. Hoekstra
Dirk Th. Sleijfer
Joke Fleer
Damon J. Vidrine
Ellen R. Gritz
Josette E. H. M. Hoekstra-Weebers
Publication date
01-03-2007
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 3/2007
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-006-0119-5

Other articles of this Issue 3/2007

Supportive Care in Cancer 3/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine